Quantitative analysis and pharmacokinetic study of a novel diarylurea EGFR inhibitor (ZCJ14) in rat plasma using a validated LC-MS/MS method

Data publikacji: 31 gru 2020

Zakres stron: 415 - 428

Przyjęty: 04 sie 2020

DOI: https://doi.org/10.2478/acph-2021-0024

Słowa kluczowe

ZCJ14, epidermal growth factor receptor inhibitor, LC-MS/MS, pharmacokinetics, bioavailability

© 2021 Sai-Jie Zuo et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.